Humana ABLTS:0RF7 +3.44%67 Net Margin % is 1.53% as of Mar. 2026, which is 37% below its 10-year median of 2.44. GuruFocus rates LTS:0RF7 with a GF Score™ of 67/100 and a GF Value™ of kr36.46 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Humana AB ranks worse than 53.89% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Humana AB's Net Income for the
three
months ended in Mar. 2026 was kr38 Mil. Humana AB's Revenue for the
three
months ended in Mar. 2026 was kr2,479 Mil. Therefore, Humana AB's net margin for the quarter that ended in Mar. 2026 was 1.53%.
The historical rank and industry rank for Humana AB's Net Margin % or its related term are showing as below:
LTS:0RF7'
s Net Margin % Range Over the Past 10 Years
Min: 1.4 Med: 2.44 Max: 3.66
Current: 2
LTS:0RF7's Net Margin % is ranked worse than 53.89% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs LTS:0RF7: 2.00
Humana AB (LTS:0RF7) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Humana AB Net Margin % Related Terms
Humana AB Net Margin % Historical Data
* Premium members only.
The historical data trend for Humana AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RF7 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Humana AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Humana AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humana AB (LTS:0RF7) has a Net Margin % of 1.53% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Humana AB and its competitors. This is 37% below median its historical median of 2.44. Over the past decade, Humana AB's Net Margin % has ranged from 1.40 to 3.66. According to the industry distribution chart, Humana AB ranks #360 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 53.9%.
Is Humana AB's Net Margin % too high?
Humana AB's current Net Margin % of 1.53% is 37% below median its 10-year median of 2.44. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 3.66. The Healthcare Providers & Services industry median Net Margin % is 2.89. Humana AB's value of 1.53% is 47% below this industry median. Based on the distribution chart, Humana AB ranks #360 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Humana AB has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #360 out of 668 companies for Net Margin %. This places Humana AB in the lower half of its industry. The industry median Net Margin % is 2.89. Humana AB's value of 1.53% is 47% below this benchmark. Historically, Humana AB's own Net Margin % has ranged from 1.40 to 3.66 over the past decade. While the company's 10-year median is 2.44 vs. the industry median of 2.89, Humana AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current Net Margin % of 1.53% is 47% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current Net Margin % is 1.53%, which is 37% below median its own 10-year median of 2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr36.46, compared to a current price of kr48.13 — trading 32% above its estimated fair value. The current Net Margin % is 1.53%, which is 37% below median its 10-year median of 2.44 and 47% below the Healthcare Providers & Services industry median of 2.89. Humana AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current Net Margin % is 1.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr48.13 is trading 32% above its estimated GF Value™ of kr36.46.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
Net Margin %: 1.53% (37% below median its 10-year median of 2.44)
GF Value™: kr36.46 vs. price of kr48.13 (32% above fair value)
Industry Position: 47% below the Healthcare Providers & Services median (#360 of 668)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
67GF Score
Get the complete analysis for LTS:0RF7
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
